← Evidence map

ArticlePharmaceutics2021

Structural Polymorphism of Sorafenib Tosylate as a Key Factor in Its Solubility Differentiation.

Gabriela Wiergowska et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

6 papers cite it

2021
2022
2023
2024
2025
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 33805754